Patent ID: 7888378
Filing Date: 2011-02-15
Classification: A61P,C07D

Abstract:
1. A method of performing a phototherapy procedure, the method comprising: administering to a patient an effective amount of a compound of Formula I to a target tissue; and exposing the administered compound at the target tissue to light of wavelength between 300 nm and 1200 nm sufficient to result in injury or death to cells at the target tissue, wherein the target tissue is a tumor or lesion, wherein: each of R each of b and c independently varies from 0 to 3; X is —O—, —NR each of R a varies from 0 to 10; each of R each E is independently hydrogen, a whole or fragmented somatostatin receptor binding molecule, a whole or fragmented ST receptor binding molecule, a whole or fragmented neurotensin receptor binding molecule, a whole or fragmented bombesin receptor binding molecule, a whole or fragmented CCK receptor binding molecule, a whole or fragmented steroid receptor binding molecule, or a whole or fragmented carbohydrate receptor binding molecule.